-

Glenn Youngkin, 74th Governor of Virginia and former Carlyle Co-CEO, Joins Red Cell Partners as Chairman

MCLEAN, Va.--(BUSINESS WIRE)--Red Cell Partners announced today that the 74th Governor of Virginia and former Co-CEO of The Carlyle Group, Glenn Youngkin, has joined as partner, chairman, and board member. Founded in 2020, Red Cell launches, scales, and operates national security, cyber, and healthcare technology companies.

“Red Cell is redefining the start-up and venture capital formula by bringing together true visionaries, deep sector and operating expertise, and capital—both their own funds and world-class venture partners. I can’t overstate how much energy this place has, with recent landmark successes of companies built at Red Cell, like Trase, Claros, and Hunted Labs, plus investments like Epirus. By specializing in national security, cyber, and health care, Red Cell is creating solutions to problems that are both mission-critical for those industries and our country,” said former Governor Youngkin. “My friend Grant Verstandig and the Red Cell leadership team have already launched numerous breakout companies in just a few years, and I’m excited to help them grow even faster.”

Red Cell was founded by Verstandig after he sold his first company, Rally Health—a consumer-centric health company—to UnitedHealth Group in 2017 for $4 billion, which represented one of the largest digital health exits at the time. A Washington, D.C. native, Verstandig is a serial entrepreneur who, in addition to founding Rally, co-founded multiple businesses, including Epirus, Trase, and several other Red Cell portfolio companies.

“Governor Youngkin has built a remarkable career tackling complex challenges at the highest levels of business and in government to drive meaningful change not only for the people of Virginia, but for this country,” said Grant Verstandig, founder and CEO of Red Cell Partners. “The industries we work in are the hardest and most consequential to America's future. Transforming them requires people like Governor Youngkin, people who know how to run things and who aren't afraid to break from the status quo. I’m deeply honored to welcome him to Red Cell."

About Red Cell

Red Cell Partners is a venture studio building rapidly scalable technology-led companies that are bringing revolutionary advancements to market in healthcare, cyber, and national security. United by a shared sense of duty and deep belief in the power of innovation, Red Cell is developing powerful tools and solutions to address our Nation’s most pressing problems. Visit us at redcellpartners.com and follow us on social media (LinkedIn, X, Instagram).

Contacts

press@redcellpartners.com

Industry:

Red Cell Partners

Release Versions
English

Contacts

press@redcellpartners.com

More News From Red Cell Partners

CDAO Awards Red Cell Partners $100M Agreement to Pilot Shared Savings

MCLEAN, Va.--(BUSINESS WIRE)--Red Cell Partners announces a one-year agreement with the Department of War’s Chief Digital and Artificial Intelligence Office (CDAO) with a ceiling of up to $100 million. The agreement pilots shared savings, a contracting framework in which vendors are paid only for the costs they eliminate and the outcomes they deliver. For nearly two years, Red Cell worked with CDAO and the Navy to define how the DoW could significantly reduce costs by improving efficiency throu...

Red Cell Welcomes Sean O’Keefe as Deputy CTO

MCLEAN, Va.--(BUSINESS WIRE)--Red Cell Partners today announced that Google and Function Health veteran Sean O’Keefe has joined the firm as Deputy Chief Technology Officer. O’Keefe is responsible for overseeing the implementation of Red Cell’s technology strategy, leading daily engineering operations and workflows, and managing the firm’s engineering teams. “Sean is a brilliant, mission-driven, and highly regarded leader whose deep experience across advanced engineering, AI, data science, and r...

Crux Emerges from Stealth with $6.5 Million in Funding, Launches First-Ever No-Cost Benefit to Make Popular Quality-of-Life Medications More Affordable

MCLEAN, Va.--(BUSINESS WIRE)--Crux, the first benefits platform partnering with big pharma and employers of all sizes to expand transparent and affordable access to transformative quality-of-life (QoL) medications, today announced its public launch with $6.5 million in pre-seed funding from Red Cell Partners, a venture studio that builds rapidly scalable, technology-led companies that are bringing revolutionary advancements to market in critical industries like healthcare. U.S.-based employers...
Back to Newsroom